🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A growing number of patients with Crohn's disease are treated with immunosu...
Status
Completed
Location
Yonsei University: Wonju Christian Hospital
Start Date
2011-12
Trial ID
NCT01505855
Treatments Being Tested
That anti-TNF therapy and rituximab therapy are equally effective in treati...
Status
Completed
Location
NHS Fife
Start Date
2010-04
Trial ID
NCT01021735
Treatments Being Tested
This trial is studying the safety and tolerability of receiving an injectio...
Status
Not Yet Recruiting
Location
Massachusetts Eye and Ear
Start Date
2026-06-01
Trial ID
NCT06926478
Treatments Being Tested
This investigation will be conducted to obtain the following information re...
Status
Completed
Location
Multiple Locations
Start Date
2013-08-09
Trial ID
NCT01947816
Crohn's disease (CD) is an incurable chronic inflammatory disorder of the g...
Status
Completed
Location
Peking University Third Hospital /ID# 242803
Start Date
2022-06-29
Trial ID
NCT05394805
The purpose of this study is to evaluate the efficacy and safety of vedoliz...
Status
Completed
Location
IMC - Diagnostic and Medical Clinic
Start Date
2015-06-29
Trial ID
NCT02497469
Treatments Being Tested
This trial will investigate the pharmacokinetics, safety and tolerability o...
Status
Completed
Location
1297.1.002 Boehringer Ingelheim Investigational Site
Start Date
2011-12-01
Trial ID
NCT01505491
Treatments Being Tested
This study of Humira will be conducted to obtain information on the safety ...
Status
Completed
Location
Multiple Locations
Start Date
2011-12-16
Trial ID
NCT01464333
To evaluate the safety profile, the effectiveness and the economic impact o...
Status
Completed
Location
Multiple Locations
Start Date
2007-09
Trial ID
NCT00513370
Treatments Being Tested
The objectives were: (1) To demonstrate the efficacy of adalimumab in the l...
Status
Completed
Location
Gastroenterology Associates of the East Bay
Start Date
2002-08
Trial ID
NCT01070303
Treatments Being Tested